Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06339541
What this trial is testing

The ACC Preclinical Research Platform for Precision Oncology

Who this might be right for
Solid TumorHematologic Neoplasms
Fondazione del Piemonte per l'Oncologia 250
Large-scale testing (Phase 3)Study completedNCT02650791
What this trial is testing

Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study

Who this might be right for
Hematologic Neoplasms
Ottawa Hospital Research Institute 100
Early research (Phase 1)Study completedNCT01321346
What this trial is testing

Panobinostat In Children With Refractory Hematologic Malignancies

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, ChildhoodHodgkin's Disease+1 more
Therapeutic Advances in Childhood Leukemia Consortium 30
Large-scale testing (Phase 3)UnknownNCT01015742
What this trial is testing

Unrelated Double Umbilical Cord Blood Units Transplantation

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myeloid, Chronic
Tehran University of Medical Sciences 10
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Early research (Phase 1)WithdrawnNCT04605614
What this trial is testing

64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00669578
What this trial is testing

CC-4047 in Treating Patients With Myelofibrosis

Who this might be right for
Chronic Myeloproliferative DisordersSecondary Myelofibrosis
Mayo Clinic 77
Not applicableUnknownNCT05735704
What this trial is testing

Early Detection and Screening of Hematological Malignancies - SANGUINE

Who this might be right for
Hematologic Malignancy
JaxBio Ltd 3,000
Not applicableStudy completedNCT02504047
What this trial is testing

Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood Units

Who this might be right for
Hematologic Neoplasms
University of Calgary 40
Not applicableUnknownNCT02386332
What this trial is testing

Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Instituto de Investigacion Sanitaria La Fe 206
Not applicableLooking for participantsNCT07445893
What this trial is testing

A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

Who this might be right for
Polycythemia Vera (PV)
Duan Minghui 30
Testing effectiveness (Phase 2)Study completedNCT01732393
What this trial is testing

Effect of Quercetin in Prevention and Treatment of Oral Mucositis

Who this might be right for
Chemotherapy Induced Oral Mucositis
Mashhad University of Medical Sciences 20
Not applicableEnded earlyNCT00008216
What this trial is testing

Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Adult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more
Columbia University 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05304754
What this trial is testing

"Phase I / II Study on Infusion of Natural Killer Cells After Haploidentical Transplantation in Pediatric Patients"

Who this might be right for
High-risk Leukemias
Instituto de Investigación Hospital Universitario La Paz 18
Testing effectiveness (Phase 2)Ended earlyNCT03075553
What this trial is testing

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 Infection+14 more
Mayo Clinic 12
Testing effectiveness (Phase 2)Study completedNCT00810602
What this trial is testing

Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant

Who this might be right for
Hematologic MalignanciesGraft vs Host Disease
Pavan Reddy, MD 61
Testing effectiveness (Phase 2)Ended earlyNCT01875237
What this trial is testing

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

Who this might be right for
LeukemiaMyelomaMyeloproliferative Diseases
M.D. Anderson Cancer Center 3
Not applicableNot Yet RecruitingNCT06923670
What this trial is testing

Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History

Who this might be right for
Polycythemia VeraEssential ThrombocythaemiaMyelofibrosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 496
Not applicableLooking for participantsNCT05882773
What this trial is testing

Asian Myeloproliferative Neoplasm (MPN) Registry

Who this might be right for
Myeloproliferative NeoplasmPolycythemia VeraEssential Thrombocythemia+5 more
The University of Hong Kong 1,000
Early research (Phase 1)Study completedNCT03955783
What this trial is testing

Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies

Who this might be right for
Diffuse Large B-cell LymphomaAcute Myeloid LeukemiaNon-Hodgkin's Lymphoma
Sanjay Mohan 78
Next Page